Dementia Registry for Parkinson's Disease
Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · Nov 30, 2010
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patient who is diagnosed as clinical PD with and without dementia according to the DSM-IV criteria \[3\] will be invited for this study. The diagnosis of clinical PD is according to the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria \[17\]. The initial symptom more than one year of clinical PD will be invited for this study.
- • 2. A reliable caregiver who lives with the subjects or has at least 10 hours/week of contact with the subject.
- • 3. Males and females between the ages of 50 and 90 years, inclusive.
- • 4. Adequate visual and auditory abilities to perform all aspects of the study assessments.
- Exclusion Criteria:
- Presence of any of the following criteria will exclude the subject from enrollment in the study:
- • 1. Significant neurological disease other than PD that may affect cognition.
- • 2. Current clinically important systemic illness that is likely to result in deterioration of the subject's condition or affect the subject's safety during the study.
- • 3. History of clinically evident stroke.
- • 4. History of seizures within the past 5 years
- • 5. Myocardial infarction within the past one year prior to screening
- • 6. Current DSM-IV-TR diagnosis of substance abuse or dependence (including alcohol abuse or dependence but excluding nicotine dependence) or history of substance dependence within the past 2 years to screening.
- • 7. Regular use of anticholingeric drugs within 60 days prior to screening.
- • 8. The subject received deep brain stimulation
About China Medical University Hospital
China Medical University Hospital is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. Affiliated with China Medical University, the hospital is renowned for its comprehensive approach to medical education and research, fostering collaboration between healthcare professionals and academic experts. With state-of-the-art facilities and a commitment to ethical standards, the hospital conducts rigorous clinical trials aimed at improving treatment outcomes across various medical disciplines, contributing significantly to both local and global healthcare advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Taichung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials